Identifying Biomarkers for Tuberculosis Diagnosis
Author Information
Author(s): Lu Chanyi, Wu Jing, Wang Honghai, Wang Sen, Diao Ni, Wang Feifei, Gao Yan, Chen Jiazhen, Shao Lingyun, Weng Xinhua, Zhang Ying, Zhang Wenhong
Primary Institution: Huashan Hospital, Fudan University, Shanghai, China
Hypothesis
This study aimed to identify immune factors associated with Mycobacterium tuberculosis infection and novel biomarkers that can distinguish active disease from latent infection.
Conclusion
The study identified a combination of three genes, CXCL10, ATP10A, and TLR6, as novel biomarkers for distinguishing active tuberculosis from latent infection.
Supporting Evidence
- The study identified 506 differentially expressed genes associated with tuberculosis infection.
- Validation studies confirmed the expression patterns of 81% of the microarray identified genes.
- The combination of CXCL10, ATP10A, and TLR6 provided a sensitivity of 71% and specificity of 89% in distinguishing TB from LTBI.
Takeaway
Researchers found three genes that can help tell if someone has active tuberculosis or just a latent infection, which is important for treatment.
Methodology
The study used microarray analysis and quantitative real-time PCR to analyze gene expression in peripheral blood mononuclear cells from individuals with tuberculosis, latent tuberculosis infection, and healthy controls.
Potential Biases
Potential bias due to the selection of participants from a BCG-vaccinated population.
Limitations
The study was limited to a specific population and may not be generalizable to all demographics.
Participant Demographics
Participants included 25 TB patients, 36 individuals with latent TB infection, and 22 healthy controls, with a mix of genders and ages ranging from 14 to 86 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website